Gilberto Lopes | touchONCOLOGY

Quality Cancer Care: Not Just a Matter of Anti-cancer Medicines [Press Statement]

Genetic Subtypes of DLBCL Uncovered

Large National Sequencing Projects in Europe

Non-Epithelial Ovarian Cancer: ESMO Clinical Practice Guidelines

Information on Eligibility and Enrolment of Obese Participants in Cancer Randomised Clinical Trials Underreported

ESMO Asia 2018: Registration

Sylvester Comprehensive Cancer Center, University of Miami, FL, US

Authored articles:

Can we Continue to Afford Access to Cancer Treatment?

Nils Wilking, Gilberto Lopes, Klaus Meier, Steven Simoens, Wim van Harten, Arnold Vulto

European Oncology & Haematology

European Oncology & Haematology, 2017;13(2):114–9 DOI: https://doi.org/10.17925/EOH.2017.13.02.114

What Happens when the Cost of Cancer Care Becomes Unsustainable?

Steven Simoens, Wim van Harten, Gilberto Lopes, Arnold Vulto, Klaus Meier, Nils Wilking

European Oncology & Haematology

European Oncology & Haematology, 2017;13(2):108–13 DOI: https://doi.org/10.17925/EOH.2017.13.02.108

Potential Solutions for Sustaining the Costs of Cancer Drugs

Gilberto Lopes, Arnold Vulto, Nils Wilking, Wim van Harten, Klaus Meier, Steven Simoens

European Oncology & Haematology

European Oncology & Haematology, 2017;13(2):102–7 DOI: https://doi.org/10.17925/EOH.2017.13.02.102